Azenta Life Sciences reviews

The Company's trajectory has been a perfect business case study. The Company has never been one for culture but has devolved into a toxic calamity. The remaining employees who stayed after the sale of Brooks have been foisted with new roles and responsibilities and or alienated by new management leaders. Constructive feedback and proposals are ignored by management if they feel it will reflect badly on them, and weekend work has become the new required normal. New employees are not properly trained and are quickly overburdened. There are too many directors and above and not enough workers to complete tasks within deadlines. Many of these directors will only delegate work to saturated teams rather than jump in and help. The inability to attract and retain experienced and credentialed employees have exacerbated these issues. For the average employee, the salary is mediocre. Taking all the variables into account, it would be hard to rationalize joining this Company in its current state until major changes occur. This used to be a fairly decent place to work...it is unfortunate to see how the Company devolved.

Constant changes with management and organization